Third Pole Therapeutics
PrivateLast Round
Convertible Debt
Mar 13, 2025
Total Funding Raised
$123.38M
Company Overview
Third Pole Therapeutics is a medical device company that develops innovative portable inhalation devices capable of generating nitric oxide on-demand to provide life-saving therapies for various cardiopulmonary conditions.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotech Equipment
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Third Pole Therapeutics Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Third Pole Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Convertible Debt | Mar 13, 2025 | ||||
| Series B | Feb 12, 2024 | ||||
| Series B | Dec 14, 2022 | ||||
| Series B | Feb 3, 2022 | ||||
| Debt | Apr 15, 2021 | ||||
Series B | Mar 5, 2019 |
Key People
Founding team and executive leadership
Third Pole Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Heart, Lung, and Blood Institute | Series B, Grant |
| National Center for Advancing Translational Sciences | Series B |
| Saturn Partners | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 12, 2024
$55M round closed.
- Apr 15, 2021
$15M round led by Avenue Venture Opportunities Fund.
Third Pole Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Third Pole Therapeutics's valuation, stock price, and market status.